Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
Year: 2015
Type: review
Abstract: The implementation of nanomedicine in cellular, preclinical, and clinical studies has led to exciting advances ranging from fundamental to translational, particularly in the field of cancer. Many of the current barriers in cancer treatment are being successfully addressed using nanotechnology-modified compounds. These barriers include drug resistance leading to suboptimal intratumoral retention, poor circulation times resulting in decreased efficacy, and off-target toxicity, among others. The first clinical nanomedicine advances to overcome these issues were based on monotherapy, where small-molecule and nucleic acid delivery demonstrated substantial improvements over unmodified drug administration. Recent preclinical studies have shown that combination nanotherapies, composed of either multiple classes of nanomaterials or a single nanoplatform functionalized with several therapeutic agents, can image and treat tumors with improved efficacy over single-compound delivery. Among the many promising nanomaterials that are being developed, nanodiamonds have received increasing attention because of the unique chemical-mechanical properties on their faceted surfaces. More recently, nanodiamond-based drug delivery has been included in the rational and systematic design of optimal therapeutic combinations using an implicitly de-risked drug development platform technology, termed Phenotypic Personalized Medicine-Drug Development (PPM-DD). The application of PPM-DD to rapidly identify globally optimized drug combinations successfully addressed a pervasive challenge confronting all aspects of drug development, both nano and non-nano. This review will examine various nanomaterials and the use of PPM-DD to optimize the efficacy and safety of current and future cancer treatment. How this platform can accelerate combinatorial nanomedicine and the broader pharmaceutical industry toward unprecedented clinical impact will also be discussed.
Source: Science Advances
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $4,500
Funders: National Science Foundation, Wallace H. Coulter Foundation, V Foundation for Cancer Research, American Academy of Implant Dentistry, British Sedimentological Research Group, Society for Laboratory Automation and Screening, National Research Foundation, National Research Foundation Singapore, Ministry of Education - Singapore, National Cancer Institute - Singapore, National Institutes of Health, National Medical Research Council, Cancer Science Institute of Singapore, National University of Singapore, National Cancer Institute, Division of Materials Research, Division of Civil, Mechanical and Manufacturing Innovation
Awards: G1021966277, G1088317241, Integrative Modeling/Simulation and Experimental Validation of Therapeutic Nanodiamond Materials, NSEC: Center for Scalable and Integrated Nano Manufacturing (SINAM), CAREER: Scalable Fabrication of Nanodiamond Patch Platforms for Sustained Drug Release, G177943796, G2059857995, G2162427718, G2372851049, G2449092862, G2787548060, G301698100, G3359027590, G3387330441, G3736831427, G374831784, G3838341945, G4341066822, G4716545851, G5438777464, G5593417214, G5703207215, Multifunctional Nanodiamond Platforms for Targeted Imaging and Therapy, G6329146606, G644245767, G6635582311, G6711204355, Nanomaterials for Cancer Diagnostics and Therapeutics, G7544127174, G7931348008, G8157925000, G8375937414, US-Taiwan Planning Visit: Interrogating Nanodiamond-Cellular Interactions, G874255506
OpenAlex ID: W2181111652
